<DOC>
	<DOC>NCT02346643</DOC>
	<brief_summary>11-SMI-2013 is a post market, observational, questionnaire based study to assess the effectiveness of the commercially available Axium neurostimulator in the management of intractable, chronic pain</brief_summary>
	<brief_title>A Post Market Evaluation of Chronic intractaBle paIN and the Efficacy of drG stimulatiOn in the Nordic Region</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Pain, Intractable</mesh_term>
	<criteria>1. Subject is at least 18 years old 2. Subject is able and willing to comply with the followup schedule and protocol 3. Chronic, intractable pain for at least 6 months 4. Failed conservative treatments for chronic pain including but not limited to pharmacological therapy, physical therapy and interventional pain procedures for chronic pain 5. Minimum baseline pain rating of 60 mm on the VAS in the primary region of pain 6. Subject is able to provide written informed consent 1. Female subject of childbearing potential is pregnant/nursing or plans to become pregnant during the study duration 2. Escalating or changing pain condition within the past month as evidenced by investigator examination 3. Subject has had corticosteroid therapy at an intended site of stimulation within the past 30 days 4. Subject has had radiofrequency treatment of an intended target DRG within the past 3 months 5. Subject currently has an active implantable device including ICD, pacemaker, spinal cord stimulator or intrathecal drug pump 6. Subject is unable to operate the device 7. Subjects currently has an active infection 8. Subject has participated in another clinical investigation within 30 days 9. Subject has a coagulation disorder or uses anticoagulants that, in the opinion of the investigator, precludes participation 10. Subject has been diagnosed with cancer in the past 2 years.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>